StudyRareStudyRare
Log in to add personal notes on this page.

A 14-year-old girl faints while swimming at a swim meet. ECG reveals a QTc of 480 ms. Her mother has a history of syncope and takes beta-blockers.

AD; cardiac ion channel genes; loss of function in the potassium channel genes KCNQ1 and KCNH2, gain of function in the sodium channel gene SCN5A.

  • LQT1: KCNQ1 (35%) - triggers: exercise (especially swimming), emotion
  • LQT2: KCNH2 (30%) - triggers: auditory stimuli, emotion, rest
  • LQT3: SCN5A (10%) - triggers: sleep/rest

The QT interval tracks how long the ventricular action potential lasts, and the action potential ends when outward potassium currents repolarize the cell. Anything that lowers the net repolarizing current lengthens it, and the three main genes do this from opposite sides:

  • LQT1 and LQT2: KCNQ1 and KCNH2 encode the channels for the slow and rapid delayed rectifier potassium currents (IKs and IKr). Loss-of-function variants shrink these currents. KCNQ1 missense variants can act dominant negative; others act through haploinsufficiency.
  • LQT3: SCN5A encodes the cardiac sodium channel. Gain-of-function variants enlarge the late sodium current that persists into the plateau phase, which also prolongs the action potential. Loss-of-function SCN5A variants cause Brugada syndrome instead.

The mechanism shapes the clinical picture. In SCN5A-related LQTS the QT lengthens most at slow heart rates, so events occur during sleep or rest, while KCNQ1 events cluster with exercise and emotion. It also guides treatment: late sodium current blockers such as mexiletine shorten the QTc in selected SCN5A variants, and potassium supplementation helps LQT2 because IKr depends on extracellular potassium.

  • Prolonged QTc (>460 ms females, >450 ms males)
  • Syncope, seizures, sudden cardiac death
  • Triggers vary by type (see above)
  • Torsades de pointes (polymorphic VT)
  • 12-lead ECG with QTc measurement (prolonged at >450 ms in males, >460 ms in females; ≥480 ms is strongly suggestive); the Schwartz score combines ECG, symptom, and family-history criteria
  • Exercise or provocative testing and ambulatory monitoring help when the resting QTc is borderline
  • Genetic testing (KCNQ1, KCNH2, SCN5A) confirms the diagnosis, defines genotype-specific triggers and risk, and enables cascade screening of relatives
  • Beta-blockers, avoid QT-prolonging drugs, ICD in high-risk, gene-specific swimming restrictions

Long eponymous names = Long QT: Syndromes with long, hyphenated names (Jervell and Lange-Nielsen, Andersen-Tawil, Romano-Ward) are all associated with Long QT

SCN5A spectrum: SCN5A GOF = Long QT ("reGain function when you spend a LONG time with your QT"); SCN5A LOF = Brugada ("aBRUpt death in BRUgada"). The symptoms of SCN5A can Sometimes ChaNge, 5Adly, depending on GOF/LOF

Long QT syndrome
Long QT syndrome